ProCE Banner Activity

CE / CME

Mind the Gap: Strategies and Emerging Options to Improve Cancer Screening

Expert Insights

Over 600,000 Americans are estimated to die from cancer in 2022 despite advances in cancer treatment. Detecting cancer in early stages through appropriate screening is vital to improve cancer survival rates. In this activity, Eric Klein, MD discusses current early cancer screening recommendations, strengths and limitations of traditional screening methods, and strategies to improve adherence to current cancer screening recommendations. Dr Klein also provides insight into use of emerging multi-cancer early detection tests utilizing liquid biopsies to complement traditional cancer screening and ultimately improve cancer-related mortality.

Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacology credit (0.1 CEUs)

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Released: July 15, 2022

Expiration: July 14, 2023

Begin Activity

Share

Faculty

Eric Klein

Eric Klein, MD

Emeritus Professor and Chair
Glickman Urological and Kidney Institute
Cleveland Clinic
Cleveland, Ohio

Acknowledgement

This activity is supported by an educational grant from GRAIL.

Provided by

ProCE Banner

Target Audience

NPs and PAs

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe the current recommendations for early cancer screening in average-risk, asymptomatic patients and the challenges impacting their uptake

  • Apply strategies to encourage patients to adhere to cancer screening recommendations

  • Summarize emerging methodologies for early detection of multiple cancer types

Disclosure

All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Eric Klein, MD: consultant/advisor/speaker: GRAIL.

Beth Sandy, MSN, CRNP: consultant: Amgen, AstraZeneca, Janssen, Jazz, Merck, Takeda.

None of the members of the Planning Committee or staff at PCE and PACE have any relevant financial relationships to disclose, except Beth Sandy, MSN, CRNP as noted above.

Instructions for Credit

Participants wishing to earn CE/CME credit must:

  1. Review the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the post-test and evaluation form

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.

The estimated time to complete this activity is 1.00 hour.

Release date: July 15, 2022
Expiration date: July 14, 2022

Format

eNewsletter with interactive benchmarking and audio commentary

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of PACE or any educational supporter.

Accreditation

PACE

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

NP course advisor: Beth Sandy, MSN, CRNP, Abramson Cancer Center, Philadelphia, Pennsylvania

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

AAPA Credit Designation

Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until July 14, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Heather Hylton, MS, PA-C, K Health, New York, New York

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.